Catalyst Wire Dossier Catalyst Wire Dossier

CM3.1-AC100

CM3.1-AC100 · CellMed AG
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CM3.1-AC100, covering 2010-07-15 to 2011-01-19. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3.1-AC100 in Healthy Male Volunteers [Phase 1]

See pricing